Dissemin is shutting down on January 1st, 2025

Published in

Mary Ann Liebert, AIDS Research and Human Retroviruses, 1(30), p. 17-24

DOI: 10.1089/aid.2012.0235

Links

Tools

Export citation

Search in Google Scholar

Virological and Immunological Response to Antiretroviral Regimens Containing Maraviroc in HIV Type 1-Infected Patients in Clinical Practice: Role of Different Tropism Testing Results and of Concomitant Treatments

Journal article published in 2014 by Barbara Rossetti, Claudia Bianco, Lara Ines Bellazzi, Bellazzi Li, Bianca Bruzzone, Grazia Colao, Paola Corsi, Laura Monno, Gabriella Pagano, Stefania Paolucci, Grazia Punzi, Maurizio Setti, Maurizio Zazzi ORCID, Andrea De Luca
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

We assessed the immunovirological response to antiretroviral regimens containing maraviroc in HIV-infected viremic patients with viral tropism predicted by different assays. We selected antiretroviral treatment-experienced HIV-1-infected patients initiating regimens containing maraviroc after different phenotypic or genotypic viral tropism assays, with at least one HIV-1 RNA determination during follow-up. Survival analysis was employed to assess the virological response as time to HIV-1 RNA